Concomitant use of erythromycin + CYP3A inhibitors should be avoided

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1455, 2004-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Albendazole use during pregnancy should be avoided

By  

Inpharma, Vol. 1, Iss. 1281, 2001-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

The use of NSAIDs in women who know that they are pregnant should be avoided

By  

Inpharma, Vol. 1, Iss. 1277, 2001-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Drugs as CYP3A Probes, Inducers, and Inhibitors

By Liu Yi-Tong   Hao Hai-Ping   Liu Chang-Xiao   Wang Guang-Ji   Xie Hong-Guang  

Drug Metabolism Reviews, Vol. 39, Iss. 4, 2007-10 ,pp. : 699-721

Informa Healthcare

Access to resources Recommend Favorite

CYP3A4 intron 6 C>T SNP (CYP3A4*22) encodes lower CYP3A4 activity in cancer patients, as measured with probes midazolam and erythromycin

By Elens Laure   Nieuweboer Annemieke   Clarke Stephen J   Charles Kellie A   de Graan Anne-Joy   Haufroid Vincent   Mathijssen Ron HJ   van Schaik Ron HN  

Pharmacogenomics, Vol. 14, Iss. 2, 2013-01 ,pp. : 137-149

Future Medicine

Access to resources Recommend Favorite

Quantitative Correlations Among CYP3A Sensitive Substrates and Inhibitors:Literature Analysis

By  

Current Drug Metabolism, Vol. 8, Iss. 8, 2007-12 ,pp. : 810-814

Bentham Science Publishers

Access to resources Recommend Favorite